| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| PREPrenetics Global Limited | 226.73M | 14.87 | -4.09 | 40.83% | -93.53% | -33.01% | 0.03 | |
| MYGNMyriad Genetics, Inc. | 563.01M | 6.04 | -4.28 | 11.21% | -47.45% | -101.83% | 0.20 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 9.23M | 65.18M | 12.53M | 13.16M | 21.74M | 30.62M |
| Revenue Growth % | - | 6.06% | -0.81% | 0.05% | 0.65% | 0.41% |
| Cost of Goods Sold | 6.52M | 38.83M | 8.93M | 9.55M | 12.91M | 15.22M |
| COGS % of Revenue | 0.71% | 0.6% | 0.71% | 0.73% | 0.59% | 0.5% |
| Gross Profit | 2.72M | 26.34M | 3.6M | 3.62M | 8.83M | 15.4M |
| Gross Margin % | 0.29% | 0.4% | 0.29% | 0.27% | 0.41% | 0.5% |
| Gross Profit Growth % | - | 8.7% | -0.86% | 0% | 1.44% | 0.74% |
| Operating Expenses | 23.52M | 27.34M | 60.26M | 69.64M | 60.74M | 63.54M |
| OpEx % of Revenue | 2.55% | 0.42% | 4.81% | 5.29% | 2.79% | 2.08% |
| Selling, General & Admin | 17.96M | 23.11M | 53.67M | 64.08M | 49.68M | 55.37M |
| SG&A % of Revenue | 1.94% | 0.35% | 4.28% | 4.87% | 2.28% | 1.81% |
| Research & Development | 2.99M | 2.78M | 6.39M | 5.99M | 11.66M | 10.92M |
| R&D % of Revenue | 0.32% | 0.04% | 0.51% | 0.45% | 0.54% | 0.36% |
| Other Operating Expenses | 2.57M | 1.45M | 202.18K | -430K | -606.84K | -2.75M |
| Operating Income | -20.8M | -995.13K | -56.66M | -66.02M | -51.91M | -48.14M |
| Operating Margin % | -2.25% | -0.02% | -4.52% | -5.02% | -2.39% | -1.57% |
| Operating Income Growth % | - | 0.95% | -55.94% | -0.17% | 0.21% | 0.07% |
| EBITDA | -18.57M | 1.43M | -49.32M | -58.48M | -44.11M | -42.22M |
| EBITDA Margin % | -2.01% | 0.02% | -3.93% | -4.44% | -2.03% | -1.38% |
| EBITDA Growth % | - | 1.08% | -35.46% | -0.19% | 0.25% | 0.04% |
| D&A (Non-Cash Add-back) | 2.23M | 2.43M | 7.35M | 7.54M | 7.79M | 5.93M |
| EBIT | -20.8M | -3.84M | -216.51M | -225.58M | -55.69M | -57.5M |
| Net Interest Income | -53.88K | -51.52K | -42.03K | 230K | 3.8M | 1.84M |
| Interest Income | 15.51K | 8.04K | 201 | 472K | 3.92M | 2.04M |
| Interest Expense | 69.39K | 59.57K | 42.23K | 242K | 119.66K | 203K |
| Other Income/Expense | -69.39K | -2.91M | -159.89M | -159.8M | -4.76M | -9.56M |
| Pretax Income | -20.87M | -3.9M | -216.55M | -225.82M | -56.67M | -57.7M |
| Pretax Margin % | -2.26% | -0.06% | -17.28% | -17.15% | -2.61% | -1.88% |
| Income Tax | -677.47K | -1.94M | 2.57M | -245K | -269.36K | -7.87M |
| Effective Tax Rate % | 0.96% | 0.5% | 0.8% | 0.84% | 1.11% | 0.8% |
| Net Income | -20.14M | -1.94M | -174.01M | -190.45M | -62.72M | -46.3M |
| Net Margin % | -2.18% | -0.03% | -13.88% | -14.47% | -2.88% | -1.51% |
| Net Income Growth % | - | 0.9% | -88.71% | -0.09% | 0.67% | 0.26% |
| Net Income (Continuing) | -20.2M | -1.96M | -219.12M | -225.58M | -56.4M | -49.83M |
| Discontinued Operations | 0 | 0 | 45.11M | 35.12M | -8.38M | 22K |
| Minority Interest | -53.21K | -77.41K | -84.97K | 6.4M | 3.8M | 957K |
| EPS (Diluted) | -2.73 | -0.26 | -47.04 | -37.57 | -5.58 | -3.64 |
| EPS Growth % | - | 0.9% | -179.92% | 0.2% | 0.85% | 0.35% |
| EPS (Basic) | -2.73 | -0.26 | -47.04 | -37.57 | -5.58 | -3.64 |
| Diluted Shares Outstanding | 7.4M | 7.4M | 3.7M | 5.07M | 11.25M | 12.71M |
| Basic Shares Outstanding | 7.4M | 7.4M | 3.7M | 5.07M | 11.25M | 12.71M |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 15.63M | 43.96M | 106.89M | 241.81M | 93.66M | 86.15M |
| Cash & Short-Term Investments | 11.82M | 14.8M | 45.19M | 184.12M | 72.74M | 62.81M |
| Cash Only | 11.52M | 14.49M | 35.29M | 146.66M | 45.71M | 52.25M |
| Short-Term Investments | 294.06K | 314.71K | 9.91M | 37.46M | 27.03M | 10.56M |
| Accounts Receivable | 2.89M | 23.1M | 47.05M | 42.5M | 5.29M | 5.61M |
| Days Sales Outstanding | 114.34 | 129.34 | 1.37K | 1.18K | 88.87 | 66.81 |
| Inventory | 547.85K | 4.5M | 6.83M | 4.53M | 3.13M | 6.57M |
| Days Inventory Outstanding | 30.68 | 42.27 | 279.13 | 173.36 | 88.39 | 157.45 |
| Other Current Assets | 374.36K | 979.6K | 7.31M | 4.58M | 8.31M | 3.55M |
| Total Non-Current Assets | 14.06M | 34.93M | 41.61M | 70.32M | 160.51M | 127.43M |
| Property, Plant & Equipment | 2.11M | 4.69M | 13.04M | 13.1M | 5.78M | 7.81M |
| Fixed Asset Turnover | 4.37x | 13.89x | 0.96x | 1.00x | 3.76x | 3.92x |
| Goodwill | 3.85M | 3.99M | 3.98M | 33.8M | 29.17M | 37.36M |
| Intangible Assets | 6.27M | 23.96M | 23.83M | 14.79M | 13.43M | 11.57M |
| Long-Term Investments | 1.66M | 0 | 0 | 788.47K | 107.84M | 69.33M |
| Other Non-Current Assets | 161K | 2.28M | 693.55K | 7.6M | 4.27M | 1.35M |
| Total Assets | 29.69M | 78.88M | 148.51M | 312.13M | 254.17M | 213.57M |
| Asset Turnover | 0.31x | 0.83x | 0.08x | 0.04x | 0.09x | 0.14x |
| Asset Growth % | - | 1.66% | 0.88% | 1.1% | -0.19% | -0.16% |
| Total Current Liabilities | 11.9M | 47.07M | 58.74M | 57.2M | 39.48M | 36.55M |
| Accounts Payable | 2.76M | 13.44M | 9.98M | 7.29M | 1.67M | 3.67M |
| Days Payables Outstanding | 154.61 | 126.29 | 407.9 | 278.78 | 47.23 | 87.96 |
| Short-Term Debt | 0 | 15.47M | 1.67M | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 7.79M | 10.92M | 22.64M | 17.47M | 15.49M | 15.07M |
| Current Ratio | 1.31x | 0.93x | 1.82x | 4.23x | 2.37x | 2.36x |
| Quick Ratio | 1.27x | 0.84x | 1.70x | 4.15x | 2.29x | 2.18x |
| Cash Conversion Cycle | -9.6 | 45.32 | 1.24K | 1.07K | 130.03 | 136.31 |
| Total Non-Current Liabilities | 930.56K | 804.57K | 490.66M | 11.47M | 4.53M | 5.68M |
| Long-Term Debt | 124.32K | 0 | 486.4M | 0 | 0 | 0 |
| Capital Lease Obligations | 775.23K | 804.57K | 3.6M | 3.76M | 867K | 3.01M |
| Deferred Tax Liabilities | 0 | 0 | 659.5K | 3.19M | 2.62M | 2.17M |
| Other Non-Current Liabilities | 31.01K | 0 | 0 | 4.52M | 1.05M | 499K |
| Total Liabilities | 12.83M | 47.88M | 549.4M | 68.67M | 44.01M | 42.23M |
| Total Debt | 1.46M | 17.14M | 491.67M | 6.65M | 2.37M | 5.77M |
| Net Debt | -10.07M | 2.65M | 456.38M | -140.01M | -43.34M | -46.48M |
| Debt / Equity | 0.09x | 0.55x | - | 0.03x | 0.01x | 0.03x |
| Debt / EBITDA | - | 11.98x | - | - | - | - |
| Net Debt / EBITDA | - | 1.86x | - | - | - | - |
| Interest Coverage | -299.80x | -16.71x | -1341.78x | -272.82x | -433.78x | -237.16x |
| Total Equity | 16.85M | 31.01M | -400.89M | 243.46M | 210.16M | 171.35M |
| Equity Growth % | - | 0.84% | -13.93% | 1.61% | -0.14% | -0.18% |
| Book Value per Share | 2.28 | 4.19 | -108.37 | 48.03 | 18.69 | 13.49 |
| Total Shareholders' Equity | 16.91M | 31.08M | -400.81M | 237.06M | 206.36M | 170.39M |
| Common Stock | 45.69M | 15.35M | 1.49K | 13.7K | 18K | 19K |
| Retained Earnings | -41.64M | -43.58M | 0 | -408.04M | -470.77M | -517.07M |
| Treasury Stock | 0 | 0 | 0 | -661.52K | -62K | -639K |
| Accumulated OCI | 12.86M | 21.42M | -400.81M | -185.69M | -176.03M | -169.25M |
| Minority Interest | -53.21K | -77.41K | -84.97K | 6.4M | 3.8M | 957K |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | -1.88M | -2.88M | 13.42M | 14.51M | -13.76M | -28.87M |
| Operating CF Margin % | -0.2% | -0.04% | 1.07% | 1.1% | -0.63% | -0.94% |
| Operating CF Growth % | - | -0.53% | 5.66% | 0.08% | -1.95% | -1.1% |
| Net Income | -20.2M | -1.96M | -174.02M | -190.45M | -64.78M | -49.81M |
| Depreciation & Amortization | 2.23M | 2.43M | 7.35M | 7.54M | 7.79M | 5.93M |
| Stock-Based Compensation | 3.91M | 1.62M | 22.49M | 31.58M | 10.59M | 11.98M |
| Deferred Taxes | -677.47K | -1.94M | 3.73M | 7.15M | -385.84K | -7.87M |
| Other Non-Cash Items | 2.64M | 4.77M | 160.45M | 192.46M | 8.8M | 8.93M |
| Working Capital Changes | 10.21M | -7.79M | -6.59M | -33.76M | 24.21M | 1.97M |
| Change in Receivables | 1.83M | -20.09M | -24.06M | 6.97M | 37.63M | -428K |
| Change in Inventory | 415.69K | -3.75M | -2.33M | 1.26M | -1.73M | 1.32M |
| Change in Payables | 1.71M | 9.71M | -3.46M | -2.63M | -5.62M | -4.68M |
| Cash from Investing | -4.6M | -5.97M | -22.02M | -46.14M | -82.95M | 38.54M |
| Capital Expenditures | -373.86K | -3.06M | -8.55M | -6.34M | -345.29K | -1.01M |
| CapEx % of Revenue | 0.04% | 0.05% | 0.68% | 0.48% | 0.02% | 0.03% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | 12.43K | 14.75K | -3.47M | 531.99K | -76.52M | 2.02M |
| Cash from Financing | -569.14K | 11.84M | 29.32M | 143.32M | -4.7M | -3.34M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | -65.55K | 12.45M | 4.65M | 145.86M | -241.5K | -203K |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | -2.26M | -5.94M | 2M | 8.17M | -14.68M | -29.94M |
| FCF Margin % | -0.24% | -0.09% | 0.16% | 0.62% | -0.68% | -0.98% |
| FCF Growth % | - | -1.63% | 1.34% | 3.08% | -2.8% | -1.04% |
| FCF per Share | -0.31 | -0.80 | 0.54 | 1.61 | -1.31 | -2.36 |
| FCF Conversion (FCF/Net Income) | 0.09x | 1.48x | -0.08x | -0.08x | 0.22x | 0.62x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -119.52% | -8.11% | - | -78.23% | -27.65% | -24.27% |
| Return on Invested Capital (ROIC) | -229.9% | -3.69% | -95.34% | -62.31% | -28.81% | -24.76% |
| Gross Margin | 29.41% | 40.42% | 28.75% | 27.48% | 40.61% | 50.29% |
| Net Margin | -218.15% | -2.98% | -1388.44% | -1446.78% | -288.48% | -151.22% |
| Debt / Equity | 0.09x | 0.55x | - | 0.03x | 0.01x | 0.03x |
| Interest Coverage | -299.80x | -16.71x | -1341.78x | -272.82x | -433.78x | -237.16x |
| FCF Conversion | 0.09x | 1.48x | -0.08x | -0.08x | 0.22x | 0.62x |
| Revenue Growth | - | 605.93% | -80.77% | 5.04% | 65.17% | 40.83% |
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| HONG KONG | 210.93M | 12.92M | 14.27M |
| HONG KONG Growth | - | -93.88% | 10.45% |
| TAIWAN | - | 9.33M | 7.09M |
| TAIWAN Growth | - | - | -23.95% |
| UNITED STATES | - | - | 5.51M |
| UNITED STATES Growth | - | - | - |
| Rest Of The World | - | 1.18M | 972K |
| Rest Of The World Growth | - | - | -17.92% |
Prenetics Global Limited (PRE) reported $53.3M in revenue for fiscal year 2024. This represents a 477% increase from $9.2M in 2019.
Prenetics Global Limited (PRE) grew revenue by 40.8% over the past year. This is strong growth.
Prenetics Global Limited (PRE) reported a net loss of $49.8M for fiscal year 2024.
Prenetics Global Limited (PRE) has a return on equity (ROE) of -24.3%. Negative ROE indicates the company is unprofitable.
Prenetics Global Limited (PRE) had negative free cash flow of $29.9M in fiscal year 2024, likely due to heavy capital investments.